Salmonella as a biological "Trojan horse" for neoplasia: Future possibilities including brain cancer

Medical Hypotheses

Volumn 83, Issue 3, 2014, Pages 343-345

  Mlynarczyk, Gregory S A ^a   Berg, Carrie A ^a   Withrock, Isabelle C ^a   Fick, Meghan E ^a   Anderson, Stephen J ^b   Laboissonniere, Lauren A ^a   Jefferson, Matthew A ^a   Brewer, Matthew T ^a   Stock, Matthew L ^a   Lange, Jennifer K ^a   Luna, K C ^a   Acharya, Sreemoyee ^a   Kanuri, Sriharsha ^a   Sharma, Shaunik ^a   Kondru, Naveen C ^a   McCormack, Garrett R ^a   Carlson, Steve A ^a  

^a IOWA STATE UNIVERSITY   (United States)

^b Iowa State University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BACTERIAL EXTRACT (DRUG); LIPID A; LIPOPOLYSACCHARIDE; SALMONELLA SAINTPAUL NPG; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BLOOD BRAIN BARRIER; BRAIN CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CELL PROLIFERATION; GENETIC MANIPULATION; HUMAN; LIPOGENESIS; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); SALMONELLA; SALMONELLA TYPHIMURIUM; SEPSIS; SEPTIC SHOCK; TRANSPOSON; ANIMAL; ANOXIA; BOVINE; BRAIN; BRAIN NEOPLASMS; CHEMISTRY; COMPLICATION; DISEASE MODEL; MICROBIOLOGY; MUTATION; NEOPLASMS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PIG;

EQUIDAE; SALMONELLA;

ANIMALS; ANOXIA; ANTINEOPLASTIC AGENTS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; CATTLE; DISEASE MODELS, ANIMAL; HUMANS; LIPOPOLYSACCHARIDES; MUTATION; NEOPLASMS; SALMONELLA; SEPSIS; SHOCK, SEPTIC; SWINE;

EID: 84908357084     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2014.06.009     Document Type: Article

References (24)

1. McCarthy E. The toxins of William B. Coley and the treatment of bone and soft-tissue sarcomas. Iowa Orthop J 2006, 26:154-158.
2. Chorobik P., Czaplicki D., Ossyek K., Bereta J. Salmonella and cancer: from pathogens to therapeutics. Acta Biochim Pol 2013, 60:285-297.
3. Kaiser P., Hardt W. Salmonella typhimurium diarrhea: switching the mucosal epithelium from homeostasis to defense. Curr Opin Immunol 2011, 23:456-463.
4. Mayeux P. Pathobiology of lipopolysaccharide. J Toxicol Environ Health 1997, 51:415-435.
5. de Jong H., Parry C., van der Poll T., Wiersinga W. Host-pathogen interaction in invasive Salmonellosis. PLoS Pathog 2012, 8:e1002933.
6. Gianella R.A., Washington O., Gemski P., Formal S.B. Invasion of HeLa cells by Salmonella typhimurium: a model for study of invasiveness of Salmonella. J Infect Dis 1973, 128:69-75.
7. Hurley B., McCormick B. Translating tissue culture results into animal models: the case of Salmonella typhimurium. Trends Microbiol 2003, 11:562-569.
8. Stritzker J., Weibel S., Seubert C., Götz A., Tresch A., van Rooijen N., et al. Enterobacterial tumor colonization in mice depends on bacterial metabolism and macrophages but is independent of chemotaxis and motility. Int J Med Microbiol 2010, 300:449-456.
9. Li C., Chen P., Lee N., Lee H., Chang C., Lee C., et al. Non-typhoidal Salmonella bacteremia among adults: an adverse prognosis in patients with malignancy. J Microbiol Immunol Infect 2012, 45:343-349.
10. Savva A., Roger T. Targeting toll-like receptors: promising therapeutic strategies for the management of sepsis-associated pathology and infectious diseases. Front Immunol 2013, 4:387.
11. Sassi N., Paul C., Martin A., Bettaieb A., Jeannin J. Lipid A-induced responses in vivo. Adv Exp Med Biol 2009, 667:69-80.
12. Sunshine M., Gibson B., Engstrom J., Nichols W., Jones B., Apicella M. Mutation of the htrB gene in a virulent Salmonella typhimurium strain by intergeneric transduction: strain construction and phenotypic characterization. J Bacteriol 1997, 179:5521-5533.
13. Toso J., Gill V., Hwu P., Marincola F., Restifo N., Schwartzentruber D., et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 2002, 20:142-152.
14. Xiong N., Brewer M., Day T., Kimber M., Barnhill A., Carlson S. Evaluation of the pathogenicity and virulence of three strains of Salmonella organisms in calves and pigs. Am J Vet Res 2010, 71:1170-1177.
15. Neyns B., D'haeseleer M., Rogiers A., Van de Cauter J., Chaskis C., Michotte A., et al. The role of cytotoxic drugs in the treatment of central nervous system gliomas. Acta Neurol Belg 2010, 110:1-14.
16. Momiyama M., Zhao M., Kimura H., Tran B., Chishima T., Bouvet M., et al. Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model. Cell Cycle 2012, 11:628-632.
17. Feng K., Zhao H., Chen J., Yao D., Jiang X., Zhou W. Anti-angiogenesis effect on glioma of attenuated Salmonella typhimurium vaccine strain with flk-1 gene. J Huazhong Univ Sci Technolog Med Sci 2004, 24:389-391.
18. Xiong N., Brewer M., Anderson K., Carlson S. Non-typhoidal Salmonella encephalopathy involving lipopolysaccharide in cattle. Vet Microbiol 2013, 162:285-287.
19. Mody R., Greene S., Gaul L., Sever A., Pichette S., Zambrana I., et al. National outbreak of Salmonella serotype saintpaul infections: importance of Texas restaurant investigations in implicating jalapeño peppers. PLoS One 2011, 6:e16579.
20. Xiong N., Brewer M., Anderson K., Watrous G., Weeks K., Barnhill A., et al. Beta-lactam antibiotics prevent Salmonella-mediated bovine encephalopathy regardless of the beta-lactam resistance status of the bacteria. Vet J 2012, 192:535-537.
21. Stirling D., Koochesfahani K., Steeves J., Tetzlaff W. Minocycline as a neuroprotective agent. Neuroscientist 2005, 11:308-322.
22. Stock M., Fiedler K., Acharya S., Lange J., Mlynarczyk G., Anderson S., et al. Antibiotics acting as neuroprotectants via mechanisms independent of their anti-infective activities. Neuropharmacology 2013, 73:174-182.
23. Xiong N., Brewer M., Anderson K., Weeks K., Carlson S. Expression of a collagenase that enables blood-brain barrier penetration for Salmonella implicated in bovine encephalopathies. Microb Pathog 2011, 51:230-232.
24. McCuddin Z., Carlson S., Sharma V. Experimental reproduction of bovine Salmonella encephalopathy using a norepinephrine-based stress model. Vet J 2008, 175:82-88.